TIDES: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Joe Guiles, PhD
Head of Development at Agilent Technologies, Inc.


Joe is a Pharma/Biotech senior leader with extensive experience in building and leading technical functions that focus on clinical and commercial stage therapeutic API’s. He is currently the Head of Development at Agilent Technologies Nucleic Acid Solution Division in Boulder, CO. His past employers included Medivation, Cedarburg-Hauser, Replidyne, Sanofi-Aventis, and Johnson & Johnson.

Joe Guiles, PhD's Network

Agenda Sessions

  • Successful Millimole gRNA Production & Highly Resolving Purity Test Methods & Agilent SureGuide CRISPR sgRNAs

    , 2:00pm